New name for D3 Radiation Planning

Tailoring its new suite to focus more on radiation oncology, D3 Radiation Planning has changed its name to D3 Radiation Oncology Solutions.

The company's new suite includes:

• D3 Radiation Oncology Pathways, which provides treatment recommendations for individual patient presentations in a web-based interactive decision support tool;
• D3 Quality Assurance and Peer Review programs, to help achieve American College of Radiology or American College of Radiation Oncology accreditation and quality and patient safety;
• Flexible options for treatment planning, including on-demand dosimetry and other positions;
• Clinical training of advanced technology and post-training validation and peer review; and
• Commissioning, either fully outsourced or facilitated, for data collection and modeling, acceptance testing and technology.

Pittsburgh-based D3 Radiation Oncology Solutions presented its new suite at the annual meeting for the American Society of Radiation Oncology between Oct. 31 and Nov. 2 in San Diego.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.